Company news
American Diversified Holdings Corp. news in 2024
American Diversified Holdings Corp.'s news releases, calls and decks from 2024, newest first.
American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board
November 18, 2024
Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration
October 28, 2024
American Diversified Holdings Corporation (ADHC) Completes Acquisition Of GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients
September 29, 2024
American Diversified Holdings Corporation (ADHC) to Acquire GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients
September 8, 2024
American Diversified Holdings Corporation Announces the Cancellation of 466 Million Shares
August 28, 2024
American Diversified Holdings Corporation Announces a Major Debt Restructuring Eliminating $2.727 Million in Debt from Their Balance Sheet
August 25, 2024
ADHC to be debt free upon the completion of major debt restructuring
August 26, 2024
American Diversified Holdings corporation launches new artificial intelligence (AI) business division
August 19, 2024
American Diversified Holdings Corporation Launches New Artificial Intelligence (AI) Business Division
August 12, 2024
American Diversified Holdings corporation (OTC: "ADHC") retains bio device veteran, bill colone to advise on entering $585 billion bio device arena
June 3, 2024
American Diversified Holdings corporation targets $595 billion bio device market
May 29, 2024
New CEO, John Cacchioli, Esq. Approved By OTC Markets As Company Charts New Course for 2024
April 24, 2024
American diversfiied holdings corporation appoints new chairman/CEO
February 29, 2024
Resignation of CEO
February 28, 2024
ADHC announces resignation of chairman/CEO
February 22, 2024